On December 20, 2017, Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727) closed the transaction. The company amended the transaction issued 47,169,811 shares at the price of CNY 19.08 per share for gross proceeds of CNY 899,999,993.88. Ruan Hongxian acquired 5,241,090 shares for CNY 99,999,997.2 and increased holding to 180,921,090 shares.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited acquired 41,928,781 shares for CNY 799,999,996.68. The shares subscribed by investors may not be transferred within 36 months from the closing date of issuance. The total outstanding shares will increase from 520,600,000 to 567,769,811.

The sponsor and underwriting fees were CNY 20,000,000 and legal fees, information disclosure fees, securities registration fees, capital verification fees and other issuance expenses were CNY 23,790,000.00. The net proceeds were CNY 876,209,993.88.